Literature DB >> 10913391

Polyclonal Staphylococcal endocarditis caused by genetic variability.

J Van Eldere1, W E Peetermans, M Struelens, A Deplano, H Bobbaers.   

Abstract

Cultures of blood obtained from a patient with Staphylococcus epidermidis prosthetic valve endocarditis yielded 15 strains of S. epidermidis. Genome macrorestriction and amplified fragment-length polymorphism analyses of these strains showed that they belonged to 4 different, very closely related clones, suggesting that they were the result of genetic variability of an infecting strain during the infectious episode. In vivo experiments in a rat model for foreign body infections using 1 of the S. epidermidis strains from the patient showed genetic variability similar to that of the infecting strain. In the rat model, we also detected the simultaneous presence of different clones that were identical to those isolated from our patient, thus confirming the possibility of genetic variability. It is important to note that the 4 clones isolated from our patient presented with 2 different antibiograms. Therefore, in cases of foreign device-related infections due to coagulase-negative staphylococci, the possibility of polyclonal infection has to be taken into account, particularly as regards differences in antibiotic susceptibility.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10913391     DOI: 10.1086/313915

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  21 in total

Review 1.  Updated review of blood culture contamination.

Authors:  Keri K Hall; Jason A Lyman
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

2.  Inferring a population structure for Staphylococcus epidermidis from multilocus sequence typing data.

Authors:  M Miragaia; J C Thomas; I Couto; M C Enright; H de Lencastre
Journal:  J Bacteriol       Date:  2007-01-12       Impact factor: 3.490

3.  Use of colony morphology to characterize carriage profiles of coagulase negative staphylococci.

Authors:  B J Locke; F D Lowy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-12       Impact factor: 3.267

Review 4.  Blood culture contamination: persisting problems and partial progress.

Authors:  Melvin P Weinstein
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

5.  Evaluation of quantitative antibiotic susceptibility testing by Vitek 2 as a routine method to predict strain relatedness of coagulase-negative staphylococci isolated from blood cultures.

Authors:  Antonia Camerer; Anke Kohlenberg; Danuta Stefanik; Harald Seifert
Journal:  J Clin Microbiol       Date:  2011-07-27       Impact factor: 5.948

6.  Molecular analysis of Staphylococcus aureus blood isolates shows lack of polyclonal bacteremia.

Authors:  Riad Khatib; Mamta Sharma; S Anwar H Naqvi; Kathleen Riederer; Mohammed O Almoujahed; Mohamad G Fakih
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

7.  Significance of Staphylococcus epidermidis in Health Care-Associated Infections, from Contaminant to Clinically Relevant Pathogen: This Is a Wake-Up Call!

Authors:  Micael Widerström
Journal:  J Clin Microbiol       Date:  2016-05-11       Impact factor: 5.948

8.  Comparison of molecular typing methods for characterization of Staphylococcus epidermidis: proposal for clone definition.

Authors:  M Miragaia; J A Carriço; J C Thomas; I Couto; M C Enright; H de Lencastre
Journal:  J Clin Microbiol       Date:  2007-11-07       Impact factor: 5.948

9.  Comparative epidemiology of Staphylococcus epidermidis isolates from patients with catheter-related bacteremia and from healthy volunteers.

Authors:  S Cherifi; B Byl; A Deplano; C Nonhoff; O Denis; M Hallin
Journal:  J Clin Microbiol       Date:  2013-03-13       Impact factor: 5.948

10.  The role of intraoperative cultures at the time of reimplantation in the management of infected total joint arthroplasty.

Authors:  O Murillo; G Euba; L Calatayud; M A Domínguez; R Verdaguer; A Pérez; J Cabo; J Ariza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-04-23       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.